Sysmex Inostics' OncoBEAM Platform Demonstrates Superior Detection of Clinically-relevant Mutations for Therapy Selection and Molecular Monitoring for Lung and Colon Cancers - Seite 3

Sysmex Inostics' highly sensitive OncoBEAM services allow for molecular genetic analysis of cell-free tumor DNA from blood or plasma, delivering an individualized approach to complement treatment decision-making in oncology. Based on the highly sensitive BEAMing technology developed at the Johns Hopkins University School of Medicine, OncoBEAM testing is able to provide multiplex hotspot mutation analysis for the accurate and reliable detection of rare mutant molecules of tumor DNA from blood samples of patients with cancer.  Due to its minimal-invasive nature, OncoBEAM delivers new possibilities for cancer management while minimizing costs and risks inherent with tissue biopsies. The OncoBEAM assays target a wide variety of clinically actionable genetic mutations in various cancers like melanoma, colorectal, breast and lung cancer, delivering information in real-time to support therapy selection, detection of emergent mutations and assessment of drug response. In the US, OncoBEAM tests are available as GCP and CLIA services. OncoBEAM RAS CRC CE IVD kit is available in EU.

About Sysmex Inostics 

Sysmex Inostics, a subsidiary of Sysmex Corporation, is a molecular diagnostic company whose core competency is mutation detection utilizing highly sensitive technologies such as BEAMing and Plasma Safe-Sequencing. Sysmex Inostics is a trusted partner to leading pharmaceutical companies, advancing their efforts to bring the most effective personalized cancer therapies to global markets.

With BEAMing and Plasma Safe-Sequencing (SafeSeq) being some of the most sensitive technologies available today for the detection of tumor-specific somatic mutations in blood samples, Sysmex Inostics' services are readily available to support clinical trials and research in oncology.  In addition, OncoBEAM tests are available today through a CLIA-certified laboratory for routine clinical analysis.

Sysmex Inostics' headquarters and GCP Service Laboratory are located in Hamburg Germany; Sysmex Inostics' Commercial Offices and CLIA-certified and GCP Clinical Laboratory is located in Baltimore, Maryland.  For more information on Plasma Safe-Sequencing and OncoBEAM blood testing, please visit http://www.sysmex-inostics.com or email [e-mail] .

Contact:
Sysmex Inostics
Press Release
Phone [phone]
Mail [e-mail]